CY1120801T1 - Μεθοδοι και αντιδραστηρια για τη διατηρηση της βιωσιμοτητας των καρκινικων κυτταρων σε χειρουργικως αφαιρουμενο ιστο - Google Patents

Μεθοδοι και αντιδραστηρια για τη διατηρηση της βιωσιμοτητας των καρκινικων κυτταρων σε χειρουργικως αφαιρουμενο ιστο

Info

Publication number
CY1120801T1
CY1120801T1 CY181100877T CY181100877T CY1120801T1 CY 1120801 T1 CY1120801 T1 CY 1120801T1 CY 181100877 T CY181100877 T CY 181100877T CY 181100877 T CY181100877 T CY 181100877T CY 1120801 T1 CY1120801 T1 CY 1120801T1
Authority
CY
Cyprus
Prior art keywords
reagents
methods
maintaining
cancer cell
cell viability
Prior art date
Application number
CY181100877T
Other languages
Greek (el)
English (en)
Inventor
Tony K Baker
Original Assignee
Truckee Applied Genomics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Truckee Applied Genomics Llc filed Critical Truckee Applied Genomics Llc
Publication of CY1120801T1 publication Critical patent/CY1120801T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Physiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY181100877T 2013-03-15 2018-08-23 Μεθοδοι και αντιδραστηρια για τη διατηρηση της βιωσιμοτητας των καρκινικων κυτταρων σε χειρουργικως αφαιρουμενο ιστο CY1120801T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361798627P 2013-03-15 2013-03-15
PCT/US2014/029198 WO2014144682A1 (en) 2013-03-15 2014-03-14 Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue

Publications (1)

Publication Number Publication Date
CY1120801T1 true CY1120801T1 (el) 2019-12-11

Family

ID=51528685

Family Applications (1)

Application Number Title Priority Date Filing Date
CY181100877T CY1120801T1 (el) 2013-03-15 2018-08-23 Μεθοδοι και αντιδραστηρια για τη διατηρηση της βιωσιμοτητας των καρκινικων κυτταρων σε χειρουργικως αφαιρουμενο ιστο

Country Status (17)

Country Link
US (5) US9113623B2 (enExample)
EP (2) EP3581643A1 (enExample)
JP (1) JP6465857B2 (enExample)
CN (2) CN105121629B (enExample)
CA (1) CA2941929C (enExample)
CY (1) CY1120801T1 (enExample)
DK (1) DK2970878T3 (enExample)
ES (1) ES2684582T3 (enExample)
HR (1) HRP20181352T1 (enExample)
HU (1) HUE039933T2 (enExample)
LT (1) LT2970878T (enExample)
PL (1) PL2970878T3 (enExample)
PT (1) PT2970878T (enExample)
RS (1) RS57900B1 (enExample)
SI (1) SI2970878T1 (enExample)
SM (1) SMT201800457T1 (enExample)
WO (1) WO2014144682A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105121629B (zh) 2013-03-15 2020-12-18 特拉基应用基因组学有限责任公司 用于保持已手术去除的组织中的癌细胞活力的方法和试剂
US10053676B2 (en) 2014-11-25 2018-08-21 Bio-Rad Laboratories, Inc. Arginine improves polymerase storage stability
CN107333750A (zh) * 2017-06-11 2017-11-10 成都吱吖科技有限公司 一种长时血液细胞稳定剂
WO2021055170A1 (en) * 2019-09-17 2021-03-25 Longhorn Vaccines And Diagnostics, Llc Multipurpose compositions for collecting and transporting biological material
WO2022010916A1 (en) * 2020-07-07 2022-01-13 Truckee Applied Genomics, Llc Cell preservation reagents and methods of use
CN117063915B (zh) * 2023-08-17 2026-02-24 镜像绮点(上海)细胞技术有限公司 原代肿瘤细胞冻存液

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409826A (en) * 1993-06-08 1995-04-25 Coulter Corporation Preserved, non-infectious control cells prepared by the modulation or modification of normal cells
JP2000509018A (ja) * 1996-03-26 2000-07-18 イーライ・リリー・アンド・カンパニー 肥満タンパク質製剤
US20010007673A1 (en) 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
JP2001526051A (ja) 1997-12-10 2001-12-18 シエラ ダイアグノスティクス,インク. 体液中のdnaを保存するための方法及び試薬
US20080064108A1 (en) 1997-12-10 2008-03-13 Tony Baker Urine Preservation System
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
CN1230524C (zh) * 2000-12-04 2005-12-07 株式会社淋巴技术 细胞保存液和使用该保存液的细胞保存方法
KR20020066778A (ko) 2001-02-13 2002-08-21 한국과학기술연구원 체내 난흡수 물질의 흡수촉진용 조성물과 제형 및 그의제조방법
WO2008111981A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation of macromolecules
AU2003300899A1 (en) * 2002-12-12 2004-06-30 Oncotech, Inc. Genes related to sensitivity and resistance to chemotherapeutic drug treatment
US8793895B2 (en) * 2006-02-10 2014-08-05 Praxair Technology, Inc. Lyophilization system and method
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
CN101617045A (zh) 2006-09-12 2009-12-30 谢拉分子公司 使用离液剂的缓冲溶液去除核酸的分子分析干扰物
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
EP2086622A2 (en) 2006-10-27 2009-08-12 Sierra Molecular Corporation Penetratable septum cap
WO2008071384A1 (en) 2006-12-13 2008-06-19 Roche Diagnostics Gmbh Use of tde for the isolation of nucleic acids
CA2680801A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation and/or stabilizationof a cell and/or macromolecule
AU2008321382A1 (en) * 2007-11-12 2009-05-22 Bipar Sciences, Inc. Treatment of uterine cancer and ovarian cancer with a PARP inhibitor alone or in combination with anti-tumor agents
WO2010003037A2 (en) * 2008-07-03 2010-01-07 Sierra Molecular Corporation Compositions, systems, and methods for stabilization of a cell and/or macromolecule
WO2010028156A2 (en) 2008-09-04 2010-03-11 Board Of Regents, The University Of Texas System Dual modality detection of apoptosis
US9133343B2 (en) * 2009-11-30 2015-09-15 Enzo Biochem, Inc. Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications
CN102318597B (zh) * 2011-08-19 2013-04-03 张雪云 一种液基细胞保存液组合物及其制备方法
CN105121629B (zh) 2013-03-15 2020-12-18 特拉基应用基因组学有限责任公司 用于保持已手术去除的组织中的癌细胞活力的方法和试剂

Also Published As

Publication number Publication date
WO2014144682A8 (en) 2015-08-13
HUE039933T2 (hu) 2019-02-28
US20150327539A1 (en) 2015-11-19
ES2684582T3 (es) 2018-10-03
JP6465857B2 (ja) 2019-02-06
CA2941929C (en) 2021-02-23
US9949474B2 (en) 2018-04-24
SI2970878T1 (sl) 2019-02-28
HK1220481A1 (en) 2017-05-05
SMT201800457T1 (it) 2018-11-09
HRP20181352T1 (hr) 2018-12-14
WO2014144682A4 (en) 2014-12-24
US10772318B2 (en) 2020-09-15
US20160235055A1 (en) 2016-08-18
US9113623B2 (en) 2015-08-25
EP3581643A1 (en) 2019-12-18
US20150230454A1 (en) 2015-08-20
RS57900B1 (sr) 2019-01-31
US9445586B2 (en) 2016-09-20
EP2970878B1 (en) 2018-05-23
DK2970878T3 (en) 2018-09-03
LT2970878T (lt) 2018-11-12
EP2970878A1 (en) 2016-01-20
US20170215410A1 (en) 2017-08-03
CN105121629B (zh) 2020-12-18
CN105121629A (zh) 2015-12-02
PL2970878T3 (pl) 2019-01-31
PT2970878T (pt) 2018-10-09
CA2941929A1 (en) 2014-09-18
US9565852B2 (en) 2017-02-14
CN112806352A (zh) 2021-05-18
EP2970878A4 (en) 2016-08-03
US20140272921A1 (en) 2014-09-18
JP2016512693A (ja) 2016-05-09
WO2014144682A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
CY1122179T1 (el) Μεθοδοι και συνθεσεις για την παραγωγη ή την διατηρηση πολυδυναμων κυτταρων
MX2025001112A (es) Guias modificadas de arn para edicion genica
EP3597733A4 (en) THREE-DIMENSIONAL CULTURE OF PRIMARY CANCER CELLS USING TUMOR TISSUE
CY1121630T1 (el) Ρυθμιση της εκφρασης γονιδιου σφαιρινης διαμεσολαβουμενη απο νουκλεασες
PH12019501262A1 (en) Modified guide rnas
MX2015011965A (es) Metodos de creacion de bancos de celulas de alta densidad.
CY1123093T1 (el) Φαρμακοφορο για την επαγωγη του trail
MX2019012311A (es) Metodos y composiciones para modificaciones geneticas dirigidas y metodos de uso.
PH12018500927B1 (en) Liver-specific constructs, factor viii expression cassettes and methods of use thereof
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
PH12017500826A1 (en) Bioreactor using microalgae
GB2555728A (en) Cancer cell enrichment system
CY1123718T1 (el) Κυτταροκαλλιεργεια
MX2017016088A (es) Oligonucleotidos multi-conjugados definidos.
EA201690403A1 (ru) Композиции и способы для модулирования рнк
MX375786B (es) Biosintesis microbiana de ergotioneina.
GT201500245A (es) Factores de transcripción que regulan la biosíntesis de la nicotina en el tabaco
EA202191602A2 (ru) Не содержащая сыворотки среда для культивирования клеток
MX2020009670A (es) Metodos de cultivo por perfusion y usos de los mismos.
MX2017003651A (es) Métodos de establecimiento de bancos de células de densidad ultra-alta.
CR20150543A (es) Método de tratamiento de páncreas e hígado para condiciones por transplante de células madre en paredes de conducto biliar
MX382997B (es) Composiciones y metodos para mejorar la expresion genetica de pklr.
BR112017020513A2 (pt) método de produção de peixe para transplante, peixe para transplante, método de produção de espécie híbrida de peixe e espécie híbrida de peixe
PH12015502577B1 (en) Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing
WO2014144682A8 (en) Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue